1. Jamdr T, Sonmacpher J, Ellen RL, et al. Long term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia. RJMS. 2015;12(8):45-49.
2. Sumara ER, Funkaara TR, Nawrocki JW, et al. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG CoA reductase inhibitor. JCRR. 2012;17(9):890-896.
3. Tylor KI, Gonave KJ, Farmer JA, et al. CAD; new slant on the disease. JDSR. 2013;101(2):222-228.
4. Jiuymuji T, Shopandhar S, Kumar G, et al. Hyperlipidemia: Consideration point about coronary artery disease. J Ethnopharmacol. 2012;140(3):151-160.
5. Soomavadh G, Lipscombe J, Lewis GF, et al. Deterioration in renal function associated with fibrate therapy. Clin Nephrol. 2016;55(1):39-44.